|
SMITH & NEPHEW, INC. JRNY II ISRT XLPE DD RT SZ 1-2 10MM; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
|
Back to Search Results |
|
| Catalog Number |
74025712 |
| Medical Device Problem Code |
Delivered as Unsterile Product (1421)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/13/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Internal complaint reference: (b)(4).This complaint was opened by smith+nephew to document a product problem associated with a smith+nephew device.The reported problem relates to known inherent device and/or procedural risks that are appropriately documented in our risk files.Smith+nephew will continue to monitor trends in accordance with our post-market surveillance process and take necessary action as required if anticipated severity and/or occurrence rates are exceeded.Smith+nephew has no reason to suspect that the product failed to meet any specifications at the time of manufacture.Based on our review of all currently available information, we are unable to identify a definitive root cause.However, as the use of our product cannot be excluded as a potential cause or contributory factor to the reported issue, we are conservatively submitting this report in accordance with applicable regulations.If additional information becomes available that alters the conclusions of this report, a follow-up report will be submitted as required.
|
| |
|
Event or Problem Description
|
|
It was reported that during tka surgery, when removed the plastic wrap and opened implant box and the jrny ii isrt xlpe dd rt sz 1-2 10mm inside was not in sterile packaging.The procedure was completed without delay using a s+n back-up device.No injury was reported as a consequence of this issue.
|
| |
|
Additional Manufacturer Narrative
|
|
H3, h6: the associated device was returned and evaluated.The visual inspection revealed that the sterile packaging is open on the side and the implant was not inside the sterile packing when received.This inspection was conducted by naked eye.A review made by the quality engineering team revealed that based on the assessment of the device¿s sterile barrier system, the defect occurred in distribution and would not be related to a manufacturing issue.Additionally, the location where the pouches were ruptured is not the location where they are heat sealed in production.Visual inspections performed during production are set-up to detect any issues not only with the device but also with the sterile barrier system.A review of the production order did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part number over the past 12 months and for the batch number based on historical data of the device did not reveal similar events for the listed device.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.According to the packaging sequence, the component should be packed in an inner pouch, then sealed and finally placed inside an outer pouch.At this time, we have no evidence to conclude that the product failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include damage during shipping, mishandling and/or storage.Based on this investigation, the need for corrective action is not indicated.Should additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
|
| |
|
Search Alerts/Recalls
|
|
|